Clinical Trials

NCT07111494 | RECRUITING | PHASE4

22 participants

Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2026-05-01

Completion:

2026-10-15

Conditions

• Psoriatic Arthritis (PsA)

Interventions

• DRUG
• OTHER

No Results Yet

NCT07108387 | RECRUITING | PHASE2

78 participants

Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2026-01-05

Completion:

2027-06-11

Conditions

• Giant Cell Arteritis (GCA)

Interventions

• DRUG

No Results Yet

NCT07106450 | NOT_YET_RECRUITING | NA

40 participants

Training Induced Muscle-Adipose EV Communication

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2026-09-30

Completion:

2028-09-30

Conditions

• Prediabetes

Interventions

• BEHAVIORAL

No Results Yet

NCT07105020 | NOT_YET_RECRUITING | NA

40 participants

iCCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men Diagnosed With Prostate Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2027-01-31

Completion:

2028-03-28

Conditions

• Prostate Cancer

Interventions

• BEHAVIORAL

No Results Yet

NCT07104123 | RECRUITING | NA

40 participants

Substance Use in Pregnancy - Optimizing Retention in Treatment

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2026-02-02

Completion:

2026-09-01

Conditions

• Substance Use Disorder (SUD)
• Pregnancy
• Postpartum
• Contingency Management

Interventions

• OTHER
• BEHAVIORAL

No Results Yet

NCT07103746 | RECRUITING | PHASE2

30 participants

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2026-04-21

Completion:

2028-08-31

Conditions

• Autoimmune Disorders

Interventions

• DRUG

No Results Yet

NCT07103096 | COMPLETED

30 participants

Infiltration in Rheumatology With 3D Virtual Reality Headset Pilot Study for the Evaluation of Satisfaction (ICARE)

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-10

Start Date:

2025-05-28

Completion:

2026-05-28

Conditions

• Infiltration

No Results Yet

NCT07100106 | RECRUITING | PHASE1/PHASE2

285 participants

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-10-07

Completion:

2028-08-31

Conditions

• Breast Cancer

Interventions

• DRUG

No Results Yet

NCT07098988 | RECRUITING | PHASE2

107 participants

Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-08-01

Completion:

2029-03-31

Conditions

• Metastatic Non-Squamous Non-Small Cell Lung Cancer
• Adult Solid Tumor

Interventions

• BIOLOGICAL
• DRUG

No Results Yet

NCT07098936 | RECRUITING | PHASE2

57 participants

Momelotinib in VEXAS Syndrome

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-11-25

Completion:

2028-06-30

Conditions

• VEXAS Syndome
• Myelo Dysplastic Syndrome

Interventions

• DRUG

No Results Yet

NCT07090135 | RECRUITING | NA

25 participants

Power Nap With TES-TI

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-12-19

Completion:

2026-09-30

Conditions

• Non-restorative Sleep
• Healthy Volunteer

Interventions

• DEVICE

No Results Yet

NCT07088068 | RECRUITING | PHASE3

723 participants

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-08-06

Completion:

2028-06-06

Conditions

• Type 1 Diabetes Mellitus

Interventions

• DRUG
• OTHER

No Results Yet

NCT07086755 | RECRUITING | PHASE2/PHASE3

1100 participants

Vadadustat for the Treatment of Nonintubated Acute Respiratory Distress Syndrome Due to Pathogen-Associated Lung Injury

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-10-23

Completion:

2031-05-31

Conditions

• Nonintubated Acute Respiratory Distress Syndrome (ARDS)
• Pathogen-associated Lung Injury

Interventions

• DRUG

No Results Yet

NCT07083830 | NOT_YET_RECRUITING | PHASE1

24 participants

ECP-DL Cell Infusion for Induction in Living Donor Kidney (LDK) Transplants

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2026-08-30

Completion:

2028-12-25

Conditions

• Kidney Transplant Failure and Rejection
• Kidney Transplant; Complications

Interventions

• DEVICE

No Results Yet

NCT07074756 | RECRUITING | NA

202 participants

A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-09-12

Completion:

2028-08-31

Conditions

• Glioma
• Recurrent Glioma
• Recurrent Glioblastoma

Interventions

• DRUG
• PROCEDURE
• OTHER
• BEHAVIORAL

No Results Yet

NCT07072832 | ACTIVE_NOT_RECRUITING | NA

10 participants

Shelf Acetabuloplasty With 3D Printed Implants as a New Treatment for Symptomatic Adult Hip Dysplasia

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-08-08

Completion:

2028-02-01

Conditions

• Hip Dysplasia

Interventions

• DEVICE

No Results Yet

NCT07072481 | ACTIVE_NOT_RECRUITING | NA

1401 participants

Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-10-13

Completion:

2027-12-24

Conditions

• HIV/AIDS
• Sexually Transmitted Diseases

Interventions

• BEHAVIORAL

No Results Yet

NCT07070336 | RECRUITING | NA

40 participants

Neuroathletic Exercise In The Elderly

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-05-01

Completion:

2026-10-01

Conditions

• Healthy Aging

Interventions

• OTHER

No Results Yet

NCT07068945 | RECRUITING

100 participants

Study of the Transition From Child Psychiatry to Adult Psychiatry in Nice Within a Population of 17-year-old Adolescents

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-10

Start Date:

2026-04-07

Completion:

2028-09-15

Conditions

• Child Psychiatry

Interventions

• BEHAVIORAL

No Results Yet

NCT07063745 | RECRUITING | PHASE2/PHASE3

590 participants

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2026-01-02

Completion:

2031-08-12

Conditions

• Metastatic Non-small Cell Lung Cancer With MTAP Deletion

Interventions

• DRUG
• OTHER

No Results Yet

NCT07063615 | COMPLETED | NA

34 participants

Safety and Efficacy of a Topical Cream in Mild-to-Moderate Seborrheic Dermatitis

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-07-21

Completion:

2026-01-10

Conditions

• Seborrheic Dermatitis

Interventions

• OTHER

No Results Yet

NCT07061652 | RECRUITING | NA

162 participants

Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-07-03

Completion:

2026-11-01

Conditions

• Cancer
• Diabetes

Interventions

• BEHAVIORAL
• OTHER

No Results Yet

NCT07058077 | RECRUITING | PHASE2/PHASE3

153 participants

A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-08-21

Completion:

2033-12-04

Conditions

• Heterozygous Familial Hypercholesterolemia (HeFH)

Interventions

• DRUG

No Results Yet

NCT07049861 | RECRUITING | NA

6200 participants

Advancing Biopsychosocial Care Training Initiative

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-07-14

Completion:

2028-12-15

Conditions

• Weight Management
• Obesity Prevention
• Obesity and Obesity-related Medical Conditions
• Obesity and Overweight
• Obesity

Interventions

• OTHER

No Results Yet

NCT07046494 | ACTIVE_NOT_RECRUITING | PHASE2

253 participants

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-07-25

Completion:

2026-08-05

Conditions

• Bipolar 1 Disorder

Interventions

• DRUG
• OTHER

No Results Yet

NCT07044310 | RECRUITING | PHASE2

38 participants

5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-07-25

Completion:

2027-07-25

Conditions

• Anatomic Stage 0 Breast Cancer AJCC v8
• Anatomic Stage I Breast Cancer AJCC v8
• Anatomic Stage II Breast Cancer AJCC v8
• Anatomic Stage III Breast Cancer AJCC v8
• Hormone Receptor-Positive Breast Carcinoma

Interventions

• PROCEDURE
• OTHER
• DRUG

No Results Yet

NCT07041606 | RECRUITING

500 participants

An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-10

Start Date:

2025-06-24

Completion:

2027-06-30

Conditions

• Endometrial Cancer

No Results Yet

NCT07038928 | RECRUITING

600 participants

TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-10

Start Date:

2025-06-30

Completion:

2026-12-31

Conditions

• Bladder Cancer

No Results Yet

NCT07038746 | RECRUITING | PHASE1

100 participants

Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing, Immunotherapy or Oral Challenges

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-08-25

Completion:

2026-12-31

Conditions

• Hypersensitivity
• Anaphylaxis

Interventions

• DRUG

No Results Yet

NCT07030270 | RECRUITING | NA

40 participants

Comparing Surfactant Administration Through Supraglottic Airway and Thin Catheter for Preterm Infants

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2026-08-05

Completion:

2028-09-30

Conditions

• Surfactant
• Respiratory Distress Syndrome (Neonatal)

Interventions

• PROCEDURE

No Results Yet

NCT07021092 | ACTIVE_NOT_RECRUITING | NA

3000 participants

PERSON-CENTERED APPROACHES TO VIREMIA: CONNECTION, RAPPORT, AND ENGAGEMENT STUDY

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-04-01

Completion:

2027-02-28

Conditions

• HIV Viremia
• HIV -1 Infection

Interventions

• OTHER

No Results Yet

NCT07020026 | RECRUITING | PHASE2

60 participants

Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-05-12

Completion:

2027-04-30

Conditions

• Parkinson's Disease

Interventions

• DRUG

No Results Yet

NCT07009899 | NOT_YET_RECRUITING | PHASE2

34 participants

BCMA Bispecific Antibody Therapy for Post-BCMA CAR T-Cell Therapy Relapse (RECLAIM)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2026-10-01

Completion:

2028-02-01

Conditions

• Multiple Myeloma

Interventions

• DRUG

No Results Yet

NCT07009548 | ENROLLING_BY_INVITATION | PHASE4

45 participants

CytoGam for CMV Infection or Disease in Solid Organ Transplant Recipients

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-06-26

Completion:

2027-12-31

Conditions

• Cytomegalovirus (CMV) Infection

Interventions

• DRUG

No Results Yet

NCT07005180 | RECRUITING | PHASE2

36 participants

Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2026-06-30

Completion:

2026-12-31

Conditions

• Parkinson Disease

Interventions

• DRUG

No Results Yet

NCT07001930 | RECRUITING | PHASE1

90 participants

Effects of Cannabidiol on Stress and Nicotine Withdrawal

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-08-25

Completion:

2029-09-01

Conditions

• CBD
• Stress
• Nicotine Dependence
• Tobacco Smoking

Interventions

• DRUG

No Results Yet

NCT07001475 | COMPLETED | PHASE1

78 participants

A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperactivity Disorder

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-08-12

Completion:

2026-08-06

Conditions

• Borderline Personality Disorder
• Attention Deficit Hyperactivity Disorder

Interventions

• DRUG

No Results Yet

NCT06999902 | COMPLETED | PHASE2/PHASE3

255 participants

Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2024-12-11

Completion:

2026-05-14

Conditions

• Focal Seizure

Interventions

• DRUG

No Results Yet

NCT06998524 | RECRUITING | PHASE3

75 participants

A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-06-27

Completion:

2027-04-30

Conditions

• Von Willebrand Disease, Type 3

Interventions

• DRUG

No Results Yet

NCT06998407 | RECRUITING | PHASE1/PHASE2

380 participants

ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-10

Start Date:

2025-08-20

Completion:

2028-08-31

Conditions

• HR+/HER2- Breast Cancer
• HR+, HER2-, Advanced Breast Cancer

Interventions

• DRUG

No Results Yet